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A  suitable initial exposure of an individual to an antigen typically results in 
the development of a  specific and persisting altered  reactivity manifested by 
facilitation of subsequent responses to that antigen. Components of such facili- 
tation characteristically include a  heightened response,  earlier appearance of a 
detectable response,  more rapid development of peak values,  the  capacity  to 
respond in the presence of specific antibody,  and,  in the case of antibody re- 
sponses,  parallel  production  of  IgM  and  IgG  immunoglobulins (1-5).  These 
features have been chiefly delineated by in vivo studies and the purpose of the 
present work was to examine the extent to which they occur in vitro. 
Materials and Methods 
Mice.--Female DBA/2 mice (Jackson Laboratories, Bar Harbor, Maine) 10 wk of age or 
older provided mouse spleen cell suspensions (MSC). I Mice receiving in vivo immunization 
were matched for age with nonimmunized  controls. Swiss white mice were the source of mouse 
sera. 
Antigen.--Sterile,  washed  sheep  erythrocytes  (SRBC)  from one male gelding were  used 
throughout. 
Sera.--Late immune anti-SRBC serum was pooled  from 200 mice receiving 3 X  l0  s SRBC 
intraperitoneally 8 and 3 wk before  sacrifice. The pooled  serum had a  2-mercaptoethanol- 
insensitive hemagglutinin titer of 1:540. Early (IgM) anti-SRBC serum was pooled from 50 
mice sacrificed 3 days after receiving3 X  l0  s SRBC intraperitoneally. The serum had a hemag- 
glutinin titer of 1:32 which was abolished by 2-mercaptoethanol. Normal mouse serum was 
pooled from 50 nonimmunized  mice. All mouse sera were warmed to 56°C for 30 min, sterilized 
by ultrafiltration, and then stored in frozen portions. Fetal calf serum was supplied by Reheis 
Chemical  Co.  (Division of Armour Pharmaceutical),  Chicago,  Ill.  Guinea pig serum was 
lyophilized when fresh and used after reconstitution at a dilution of 1 : 8 as the source of com- 
plement. Rabbit anti-mouse IgG serum was prepared from rabbits immunized with immuno- 
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electrophoretically-pure mouse IgG. Lyophilized portions were reconstituted and used at a 
working dilution of 1:20. 
Immunizction.--(a)  In vivo: SRBC dose was 1.5 X  10  s intravenously. Passive immuniza- 
tion comprised 0.2 ml. of intravenous late-immune serum. (b) In vitro: Routinely cultures (ex- 
cept negative controls) received 2.5  X  10  6 SRBC.  Cultures passively immunized received 5 
#1 of late-immune serum. 
Culture Technique.--Each culture (1 ml total volume) contained 1 X  10  7 mouse spleen cells 
prepared, maintained, and given daily nutritional additive, in the manner described by Mishell 
and Dutton  (6).  Media were supplied by Grand Island Biological Company,  Grand Island, 
N.Y. 
Assay.--Cultures were assayed for direct and, using the anti-mouse IgG developing serum, 
for indirect plaque-forming cells (PFC)  by a  slide-modification of techniques previously de- 
scribed (7, 8). Slides were incubated for ~,~ hr before exposure to complement or complement- 
developing-serum mixture for a further 1~ hr. 
RESULTS 
Characterization of the Immune State.--Spleen  cell  cultures  were  prepared 
from matched groups of donors at various times after injection of 1.5  >(  l0  s 
SRBC intravenously. The 4 day in vitro response to SRBC was then assayed. 
The results,  for both  direct  (IgM-producing)  and  indirect  (IgG-producing) 
PFC are summarized in Fig. 1. 
Cultures did not produce detectable numbers of indirect PFC until the donor 
animals were more than 1 wk post-in vivo immunization. (This was in contrast 
to the indirect PFC activity induced by the in vivo immunization in the donor 
spleens, where peak values occurred on about the 6th day of the in vivo primary 
response and had fallen to less than 10% of this level by day 10.)  In vitro re- 
sponses were greatly augmented about 3 days after in vivo immunization. This 
degree of augmentation declined over the next 5 wk to a fairly stable level, only 
slightly above responses of cultures from nonimmunized mice. Mice which were 
8 or more wk post-SRBC immunization had passed into this stable phase and 
were termed "late-immune." Such mice no longer produced detectable numbers 
of indirect PFC in vitro (Fig. 1). The in vivo response of these mice was how- 
ever characterized by an early and predominant appearance of indirect PFC 
as well as by resistance to suppression by antibody, and was  invariably dis- 
tinguishable from the initial in vivo response of previously nonimmunized mice, 
as seen in a typical experiment whose results are shown in Table I. The sugges- 
tion that the in vitro response of late-immune mice resembled the response of 
nonimmune mice was further evaluated. 
Effect of Varying In Vitro Antigen Dose.--Routinely  2.5  X  106 SRBC were 
added to each culture. Over a 64-fold range around this dose, responses of both 
late-immune-  and nonimmune-derived cultures were similarly and relatively 
slightly augmented in the presence of increasing doses of antigen (Fig. 2). 
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greater responses of late-immune-derived cultures do not reflect a  significant 
change in the composition or properties of the responding cell populations. 
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FIO.  1.  Effect of in vivo immunization (1.5 X 10  ~  SRBC by vein) on the in vitro response. 
Each point represents the mean of two to four experiments in each of which the mean of 6-12 
cultures was determined. The first point (left) represents responses after no SRBC in vivo. 
Days indicated are those on which the cultures were started. 
TABLE  I 
Primary and Secondary In Vivo PFC Response of DBA/2 Mice. Effects of Passive 
Immunization  with Late Immune Serum 
SRBC 
(Days before assay)*  Anti-SRBC$ 
PFC/spleen§ 
Direct  Indirect 
4  0  67,550  18,250 
4  +  650  NIL 
60  0  400  NIL 
60 and 2  0  1,200  5,600 
60 and 4  0  9,100  136,350 
60 and 4  +  2,700  63,400 
* Groups of eight mice; each immunization 1.5 X 108 SRBC intravenously. 
$ 0.2 ml of late-immune serum 6 hr before last  injection SRBC; 0 indicates no passive 
immunization. 
§ Group means rounded to the nearest 50. 
Effect  of  Varying  Spleen  Cell  Concentration.--At  the  MSC  concentration 
routinely employed (1  X  107/ml) efficiency of the response (expressed as PFC/ 
106 MSC cultured) was close to maximum and unaffected by small variations 
of MSC  concentration. Considerable reduction in the MSC  concentration re- GORDON  N.  RADCLIFFE  AND  MICHAEL  A.  AXELRAD  849 
suited  in a  rapidly declining efficiency of response. The regression  curves  ob- 
tained for  the variation  of efficiency with MSC concentration  were similar for 
late-irmnune-  and nonimmune-derived  cultures, showing a consistent  and fairly 
uniform vertical displacement  over a wide range of concentration (Fig. 3). This 
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FIG. 2.  Comparative in vitro dose-response curves for spleen cell cultures derived from late- 
immune and nonimmune donor mice. Assays are for direct PFC and each point represents the 
mean of five cultures. 
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FIO.  3.  Relative etficiency of responses from late-immune and nonimmune derived cultures 
over  a  range  of  spleen  cell  concentrations.  Assays  enumerate  direct  PFC  and  each  point 
represents the mean of five cultures. 850  IMMUNOLOGICAL  MEMORY  IN  VITRO 
again suggested that the higher responses of late-immune-derived cultures were 
not based  on a  significant change in  the composition or properties  of the re- 
sponding system. 
Dependence on Separable Cell Types.--The primary in vitro immune response 
to SRBC is dependent on the interaction of at least two behaviorally distinct 
cell  populations.  Mosier  (9)  settled  MSC suspensions  on plastic surfaces and 
was able to separate a subpopulation of cells adherent to the surface from one 
containing the nonadherent cells.  Such subpopulations were singly essentially 
incapable of producing in vitro PFC responses but regained this ability when 
recombine& We found the response of MSC suspensions from late-immune mice 
TABLE II 
Secondary Immune Response In  Vitro. Dependence on Adherent and Nonadherent 
Cell Types 
Cells cultured*  SRBC~  PFC/culture§ 
L.R.  +  815 
L.R.  0  --  4 
M.R.  +  0 
M.R.  0  0 
L.R. +  M.R.  +  5540 
L.R. +  M.R.  0  290 
* L.R. indicates nonadherent (lymphocyte-rich) cells at 1 X  107 cells/culture. M.R. in- 
dicates adherent (macrophage-rich) cells at 1 X 106 cells/culture. 
1:0 indicates no SRBC added to cultures. 
§ Mean of duplicate assays of three to six cultures. 
was similarly dependent on adherent and nonadherent subpopulations (Table 
II). 
Effect  of Anti-SRBC  Antibody.--MSC  suspensions  from nonimmune  mice 
differed from immune suspensions in not having been exposed to anti-SRBC 
antibody in vivo. The effect of such exposure was therefore tested by comparing 
the in vitro responses of normal nonimmune suspensions with that of suspen- 
sions from nonimmune donors which  had  been  given 0.2  ml  of late-immune 
anti-SRBC serum 24 hr before sacrifice.  The results (Table III) indicated that 
in vivo exposure to a quantity of antibody sufficient to prevent the in vivo pri- 
mary response did not affect a subsequent response in vitro. 
The addition of either early (IgM) mouse anti-SRBC serum (diluted to give a 
final  hemagglutinin  titer  in  the  culture  of  1:1)  or  late-immune  mouse  anti- 
SRBC (predominantly IgG, 5 ttl added to 1 ml of culture for a final hemagglu- 
tinin  titer  of 1:2)  inhibited  the PFC responses of both nonimmune and late- 
immune spleen suspensions. Normal mouse serum (NMS) absorbed with SRBC 
was similarly diluted and added to other cultures as a  control. Such NMS, as 
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TABLE  III 
In Vivo Passive Immunization. Effects on In Vivo and In Vitro Primary 
Responses Compared 
In vivo anti-SRBC* 
SRBC:~  PFC/Io  6  spleen  cells§ 
In vivo  In vitro  In vivo  In vitro 
0  +  871 
0  +  262 
+  +  12 
+  +  215 
* +  indicates 0.2 ml of late immune serum intravenously 24 hr before active immunization. 
0 indicates no passive immunization. 
~').5 X  108 intravenously or 2.5 X  108 in vitro. 
§ Direct PFC. Means of five mice or duplicate assays of five cultures; all assays 4 days 
after active immunization. 
TABLE  IV 
Effect of In Vitro Passive Immunization and In Vivo Active Immunization on 
In Vitro Responses 
In vlvo SRBC* at time  In vitro  In vitro  Duration  of  In vitro response[I (PFC/culture) 
before culture  anti-SRBC~  SRBC§  culture  Direct  Indirect 
~ays)  (days) 
None given  0  +  4  1,869  0 
None given  +  +  4  12  0 
None given  0  0  4  14  0 
3  0  +  4  68,700  0 
3  +  +  4  592  0 
3  0  0  4  1,215  0 
8  0  +  4  29,718  0 
8  +  +  4  987  0 
8  0  0  4  706  0 
25  0  +  2  954  2,345 
25  0  +  4  4,606  9,824 
25  q-  +  4  239  2,566 
25  0  0  4  132  355 
60  0  +  4  2,393  0 
60  +  +  4  42  0 
60  0  0  4  108  0 
60and 3  0  +  4  13,690  24,912 
60and 3  +  +  4  1,119  11,280 
60and 3  0  0  4  1,202  5,201 
* 1.5  X  10  s intravenously. 
:~ +  indicates 5 g.1 of late-immune serum added to each culture  at outset; 0  indicates no 
antiserum added. 
§ +  indicates 2.5 X  108 SRBC added to each culture at outset; 0 indicates no SRBC added. 
[[ Means of duplicate assays of at least four viable cultures, each seeded with 1  X  107 
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dilution employed with unabsorbed late-immune serum,  typically had a mild 
enhancing effect on the response. 
Routinely 5 #1 of late-immune anti-SRBC mouse serum was added to the 
appropriate cultures to produce a final hemagglutination titer of 1:2. This in- 
variably produced marked specific inhibition of direct PFC responses regardless 
of the donor's immune status (Table IV). 
Indirect PFC could be shown to appear and increase in number only when the 
suspensions were obtained either from donor animals which received in vivo 
immunizations with SRBC between 1 and 6 wk before sacrifice, or from late- 
immune animals which had recently received second in vivo SRBC immuniza- 
tions. Late-immune serum  added  to indirect PFC-producing cultures almost 
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FIG.  4.  Effect on the primary in vitro direct PFC response when 5/zl of late-immune mouse 
anti-SRBC  serum was added  to cultures at the stated  times after initiation  of the cultures. 
Each bar represents the mean response of four to six cultures. 
abolished the direct PFC response but had much less effect on the generation of 
indirect PFC (Table IV). 
Insofar as cultures from both nonimmune and late-immune donors were simi- 
larly sensitive to antibody inhibition, the duration of this sensitive phase was 
assessed. We were able to confirm previous findings that the primary PFC re- 
sponse to SRBC in vitro is inhibitable by antibody only in the first 24-36 hr 
phase of the response (10). We also found a similar limited period of suscepti- 
bility for responses from late-immune MSC suspensions (Fig. 4). 
DISCUSSION 
Differences between immune and nonimmune animals cannot be solely due 
to simple quantitative changes suggested  by Burnet's initial  clonal selection 
hypothesis (11) if apparent qualitative distinctions of the secondary response are 
to be accounted for (1-5,  12-14).  The immune state must reflect in addition 
some change in the composition of the cellular population responding to reim- 
munization, as experiments testing the performance of immune cell populations 
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8 wk after immunization with 1.5  )<  10  s SRBC the response of DBA/2 mice 
to SRBC in vivo is clearly distinguishable from that of closely matched mice 
which have not been previously given SRBC injections. In our hands three in- 
variable and distinctive features of such a secondary response in vivo are: (a) 
inability to abrogate the response by administration of immune serum; (b)  the 
simultaneous generation of direct and indirect PFC from the outset of the re- 
sponse;  and  (c)  the  presence of  indirect  PFC  in  numbers  greatly exceeding 
those of direct PFC. The in vitro responses to SRBC of spleen cells from such 
late-immune and nonimmune mice were, however, essentially indistinguishable. 
Neither  late-immune nor  non-immunized  mice yielded  spleen  cell  cultures 
in which  we could detect indirect  PFC  responses/ There is a  possibility this 
deficiency indicates that cells responsible for producing indirect PFC  did not 
function well in the in vitro conditions. However, good indirect PFC responses 
occurred in cultures set up between l0 and 30 days after in vivo immunization. 
This might be more compatible with the indirect PFC response in vitro being 
dependent on a  cell type which accumulates in the spleen late in the primary 
response but subsequently migrates. The peak potential for indirect PFC forma- 
tion in vitro was about 20 days after primary in vivo immunization. This lagged 
considerably behind  the  preceeding  primary in  vivo indirect  PFC  response, 
which in our system has fallen to less than 10% of its peak by the 10th day after 
primary immunization. Thus splenic indirect PFC content did not relate to the 
capacity of derived cultures for indirect PFC generation. This suggests that, if 
poor in vitro indirect  PFC  responses are due  to the lack of a  particular  cell 
type, the cell type concerned is not the indirect PFC per se. 
Anti-SRBC antibody essentially abolished the responses of cultures from late- 
immune mice but  had little  effect on the  in  vivo response of these  animals. 
Such antibody also dramatically inhibits the primary in vivo response and the 
response of cultures from nonimmune mice. The action of administered antibody 
in  cultures from late-immune and nonimmune mice appeared similar in both 
degree and timing; it was almost totally inhibiting if present in the first 24 hr of 
the in vitro response but was not inhibiting thereafter. 
The one established difference between MSC cultures from late-immune and 
nonimmune  donors  was  that  the former gave higher  overall responses.  This 
quantitative difference was slight compared to that between MSC cultures from 
3-day immune and nonimmunized donors. Further,  we could find no evidence 
for any differences in the composition or properties of the in vitro-responding 
cell populations from these two sources. Such evidence was mainly sought by 
assessing the effect on the responses of late-immune and nonimmune cultures 
2 The detection of a  small number of indirect PFC in primary MSC cultures has been re- 
ported with the use of heavy chain-specific antisera (18). While the sensitivity of our own assay 
cannot exclude the presence of a  small proportion of indirect PFC,  it serves to establish the 
presence of a deficiency in this component of the response. 854  IMMUNOLOGICAL  MEMORY  IN  VITRO 
when the in vitro antigen concentration and the spleen cell concentration were 
varied, which resulted in parallel changes in the responses of the two groups. In 
addition,  the in vitro response of spleen cells  from late-immune animals was 
shown  to  resemble  that  of spleen  cells from nonimmune  animals  in  its  de- 
pendence on two subpopulations which could be separated by surface adherence 
(9). 
With respect to both indirect PFC production and susceptibility to inhibi- 
tion by specific antibody, responses of cultures from late-immune mice resem- 
bled the early primary in vivo response and the in vitro response of nonimune 
mice. The in vitro response of early-immune mice appeared distinct from these 
and more akin to the in vivo secondary response. Thus spleen cell cultures taken 
from mice between 10 and 30 days after in vivo immunization not only gener- 
ated indirect PFC but produced them concurrently with the production of di- 
rect PFC from the outset, in a response which was relatively insusceptible to 
inhibition by the presence of anti-SRBC antibody. 
An interpretation of the data is that the response to SRBC of MSC cultures 
from animals receiving SRBC 8 or more wk previously differs basically from the 
in vivo response of such mice, and reflects the characteristics of the cell system 
determining the response in MSC cultures from nonimmunized animals. 
Passive immunization of nonimmune mice abolished their capacity to produce 
a primary in vivo PFC response to SRBC. However, washed spleen cells from 
such passively immunized animals gave a  normal in vitro response. The pro- 
cedure of putting spleen cells into culture appears to free them from the specific 
inhibiting  effect of antibody which they would have had to contend with in 
vivo. This is compatible with the in vitro direct PFC response from late-immune 
spleen cells representing a response which is largely suppressed in vivo due to the 
continuing presence there of anti-SRBC antibody. 
The in vivo secondary response of late-immune mice is characterized by the 
antibody-insuppressible generation  of predominantly indirect PFC.  In vitro, 
spleen cells  of these mice fail to yield such a  response. It is thought possible 
that this is due to the spleen's lacking a cell type necessary for the in vivo re- 
sponse of these mice. Such a deficiency is not present 2-3 wk after in vivo im- 
munization and is rapidly corrected after in vivo reimmunization of late-im- 
mune animals. 
It is concluded that the specific adaptation determining the immune state to 
SRBC involves development of a new pathway for an antibody response, and 
that the immune mouse also fully retains an unadapted preexisting pathway 
which had served for the original early primary response. 
SLUM~_ARY 
The immune responses  to  sheep erythrocytes  of  mouse spleen  cell  suspensions 
from immune and nonimmune donors were compared in vitro. In vivo immunity GORDON  N.  RADCLIFFE  AND  MICHAEL  A.  AXELRAD  855 
was only transiently reflected in vitro, and 8 wk after in vivo immunization the 
responses of cultures from immunized and nonimmunized mice were virtually 
identical.  There appeared  to be two mechanisms for an antibody response  to 
sheep erythrocytes. The first was responsible for the early primary response and 
is unmodified in the immune animal though contributing little to subsequent in 
vivo responses due to its suppressibility by specific antibody. The second was 
expressed  in  the  in vivo secondary response but  not  on in vitro  challenge  of 
spleen cells from mice immunized many weeks previously; spleen cell cultures 
from such immune mice, freed from the antibody of the in vivo environment, 
once again demonstrate a pure primary-type response. 
We thank Miss Sandra Struthers for her skilled technical assistance. 
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